~~<i id='8F27A3FD70'><strike id='8F27A3FD70'><tt id='8F27A3FD70'><pre id='8F27A3FD70'></pre></tt></strike></i>~~

Home» focus» comprehensive

comprehensive

author：knowledge 2025-10-02 14:12:09 Page View：55337

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

focus

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Living with Hashimoto's and celiac disease, and med school, too

BriannaCelix:Havingtwoautoimmunediseasesis"my‘why’formedicine."Photoillustration:CaseySheneryforSTAT

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s